Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose co-transporter 2 (SGLT2) inhibitors are widely used antidiabetic drugs. However, to date, no studies have directly compared the effects of these two drugs on the components of the metabolic syndrome in patients with type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Cheol, Kasahara, Masato, Tanaka, Tomohiro, Satoh-Asahara, Noriko, Kusakabe, Toru, Nishimura, Kunihiro, Miyamoto, Yoshihiro, Kasama, Shu, Hosoda, Kiminori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965530/
https://www.ncbi.nlm.nih.gov/pubmed/31677134
http://dx.doi.org/10.1007/s13300-019-00717-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965530/
https://www.ncbi.nlm.nih.gov/pubmed/31677134
http://dx.doi.org/10.1007/s13300-019-00717-9

Ejemplares similares